Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Acorda Therapeutics)"
Count: 56
Selected: 0
| NCT ID | Title |
|---|
| NCT03887884 | Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder) | ||
| NCT02905227 | A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder | ||
| NCT02812394 | A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets | ||
| NCT02807675 | A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder) | ||
| NCT02663999 | A Pharmacokinetic Study to Assess Dose Proportionality, Safety and Tolerability of Diazepam Nasal Spray in Healthy Adult Volunteers | ||
| NCT02633839 | A Study of the Safety and Levodopa Pharmacokinetics Following Single Dose Administration of CVT 301 (Levodopa Inhalation Powder) in Smoking and Non-Smoking Adults | ||
| NCT02633007 | A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma | ||
| NCT02609945 | Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults | ||
| NCT02474407 | Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®) | ||
| NCT02422940 | Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine. | ||
| NCT02398461 | An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse | ||
| NCT02352363 | Randomized Safety Study of CVT-301 Compared to an Observational Control Group | ||
| NCT02316847 | An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray. | ||
| NCT02271217 | A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets. | ||
| NCT02242487 | Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes | ||
| NCT02240030 | Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes | ||
| NCT01944683 | A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure | ||
| NCT01839279 | A Study to Define the ECG Effects of Tizanidine Compared to Placebo and the Positive Control, Moxifloxacin, in Healthy Men and Women Using a Blinded ECG Evaluator: A Thorough ECG Trial | ||
| NCT01803867 | An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis | ||
| NCT01777555 | Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes | ||
| NCT01750684 | AC105 in Patients With Acute Traumatic Spinal Cord Injury | ||
| NCT01683838 | Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury | ||
| NCT01617135 | Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes | ||
| NCT01605825 | A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke | ||
| NCT01535664 | An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS) | ||
| NCT01468350 | Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy | ||
| NCT01417078 | A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode | ||
| NCT01405950 | Phase 1b Study of Tizanidine in Pediatric Patients With Cerebral Palsy | ||
| NCT01328379 | Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis | ||
| NCT01316055 | Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment | ||
| NCT01258387 | Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure | ||
| NCT00654927 | Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis | ||
| NCT00649792 | Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial | ||
| NCT00648908 | Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial | ||
| NCT00483652 | Study of Fampridine-SR Tablets in Multiple Sclerosis Patients | ||
| NCT00127530 | Study of Oral Fampridine-SR in Multiple Sclerosis | ||
| NCT00053417 | Safety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple Sclerosis | ||
| NCT00041717 | Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury | ||
| NCT03212313 | Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Tozadenant | ||
| NCT03200080 | A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users | ||
| NCT03051607 | Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease. | ||
| NCT02166346 | Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch) | ||
| NCT01975324 | A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) | ||
| NCT01811706 | Dalfampridine and Gait in Spinocerebellar Ataxias | ||
| NCT01491022 | A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease | ||
| NCT01444300 | Dalfampridine for Imbalance in Multiple Sclerosis | ||
| NCT01356940 | A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis | ||
| NCT01337986 | Ampyra for Optic Neuritis in Multiple Sclerosis | ||
| NCT01235221 | Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials. | ||
| NCT01215084 | A Pharmacokinetics (PK) and Safety Study of Oral Fampridine-PR 10 mg in Chinese, Japanese, and Caucasian Adult Healthy Volunteers |
